NYU Langone Hospital — Long Island is a hospital in Mineola, New York that is the Long Island hospital base of NYU Langone Health System. It was previously known as Nassau Hospital and later Winthrop-University Hospital.

There are 591 beds in Winthrop University Hospital.

During the past decade, Winthrop University Hospital conducted 172 clinical trials. In the 10-year time frame, 172 clinical trials started and 160 clinical trials were completed, i.e. on average, 93% percent of trials that started reached the finish line to date. In the past 5 years, 62 clinical trials started and 86 clinical trials were completed. i.e. 138.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Winthrop University Hospital" #1 sponsor was "Children's Oncology Group" with 59 trials, followed by "National Cancer Institute (NCI)" with 59 trials sponsored, "NYU Langone Health" with 32 trials sponsored, "Winthrop University Hospital" with 32 trials sponsored and "SWOG Cancer Research Network" with 32 trials sponsored. Other sponsors include 221 different institutions and companies that sponsored additional 121 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Winthrop University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 101 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Winthrop University Hospital" with 10 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 229 different institutions and companies that were collaborators in the rest 180 trials.

According to Clinical.Site data, the most researched conditions in "Winthrop University Hospital" are "Pulmonary Arterial Hypertension" (13 trials), "Breast Cancer" (11 trials), "Recurrent Neuroblastoma" (9 trials), "Pulmonary Hypertension" (8 trials) and "Recurrent Osteosarcoma" (8 trials). Many other conditions were trialed in "Winthrop University Hospital" in a lesser frequency.

Most popular intervention types in "Winthrop University Hospital" are "Drug" (268 trials), "Other" (135 trials), "Biological" (81 trials), "Procedure" (65 trials) and "Radiation" (46 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (65 trials), "Placebo" (47 trials), "Cyclophosphamide" (35 trials), "Quality-of-Life Assessment" (32 trials) and "Questionnaire Administration" (29 trials). Other intervention names were less common.

The vast majority of trials in "Winthrop University Hospital" are 356 trials for "All" genders, 58 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 152 active trials in "Winthrop University Hospital". 1 are not yet recruiting, 59 are recruiting, 90 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 197 completed trials in Winthrop University Hospital, 2 suspended trials, and 47 terminated clinical trials to date.

Out of the total trials that were conducted in Winthrop University Hospital, 17 "Phase 1" clinical trials were conducted, 93 "Phase 2" clinical trials and 167 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 65 trials that are defined as “Not Applicable".